Exercise - induced changes in cerebrospinal fluid miRNAs in Gulf War Illness, Chronic Fatigue Syndrome and sedentary control subjects

James N Baraniuk, Narayan Shivapurkar, James N Baraniuk, Narayan Shivapurkar

Abstract

Gulf War Illness (GWI) and Chronic Fatigue Syndrome (CFS) have similar profiles of pain, fatigue, cognitive dysfunction and exertional exhaustion. Post-exertional malaise suggests exercise alters central nervous system functions. Lumbar punctures were performed in GWI, CFS and control subjects after (i) overnight rest (nonexercise) or (ii) submaximal bicycle exercise. Exercise induced postural tachycardia in one third of GWI subjects (Stress Test Activated Reversible Tachycardia, START). The remainder were Stress Test Originated Phantom Perception (STOPP) subjects. MicroRNAs (miRNA) in cerebrospinal fluid were amplified by quantitative PCR. Levels were equivalent between nonexercise GWI (n = 22), CFS (n = 43) and control (n = 22) groups. After exercise, START (n = 22) had significantly lower miR-22-3p than control (n = 15) and STOPP (n = 42), but higher miR-9-3p than STOPP. All post-exercise groups had significantly reduced miR-328 and miR-608 compared to nonexercise groups; these may be markers of exercise effects on the brain. Six miRNAs were significantly elevated and 12 diminished in post-exercise START, STOPP and control compared to nonexercise groups. CFS had 12 diminished miRNAs after exercise. Despite symptom overlap of CFS, GWI and other illnesses in their differential diagnosis, exercise-induced miRNA patterns in cerebrospinal fluid indicated distinct mechanisms for post-exertional malaise in CFS and START and STOPP phenotypes of GWI.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Overlap of diagnostic criteria for CFS, GWI and major depressive disorder. Diagnostic protocols for CFS, GWI and depression selected different sets of primary and ancillary symptoms. CFS requires fatigue, then confirmation with ≥4 of 8 ancillary criteria. Active depression and other psychiatric diseases are exclusionary diagnoses for CFS. GWI requires 3 of 7 categories of symptoms. Depression requires depressed affect and anhedonia, then sufficient supporting complaints.
Figure 2
Figure 2
Kansas Criteria for Gulf War Illness scoring form based on Steele. ©JNBaraniukMD_17g13. Used with permission of the copyright holder.
Figure 3
Figure 3
Chronic Fatigue Syndrome Symptom Severity Questionnaire. ©JNBaraniukMD_17g13 Used with permission of the copyright holder.
Figure 4
Figure 4
Normalizer miRNAs. Data are shown as Ct for each miRNA (N0 normalizer). The N2 normalizer used (a) miR-489 and (b) miR-490-3p. N3 added (c) miR-127-3p. The N6 normalizer added (d) miR-433, (e) miR-124-3p, and (f) miR-183-3p. Each miRNA had ΔΔCt < 1.0 between groups, ANOVA > 0.05, FDR > 0.10, and were detectable in at least 180 of the 182 subjects. The blue line indicates Ct = 35. Nonexercise groups were control (sc0, grey circles), Chronic Fatigue Syndrome (cfs0, grey triangles), and Gulf War Illness (gwi0, grey diamonds). Post-exercise groups were control (SC, yellow circles), Chronic Fatigue Syndrome (CFS, blue triangles), and the Gulf War Illness START (green squares) and STOPP (red diamonds) phenotypes. Mean ± SD.
Figure 5
Figure 5
Intersection of miRNAs from each normalizer. The intersection of N0, N2, N3, and N6 identified 16 miRNAs that had at least 1 significant difference between groups (central yellow boxes). N0, N2 and N6 and N2, N3 and N6 added one each. Pairs of normalizers identified 6 miRNAs that were not considered significant. N0 was least selective as it identified an additional 12 miRNAs that were considered false positives. Therefore, the miRNAs selected by 3 or 4 normalizers were the set of significantly different miRNAs.
Figure 6
Figure 6
miRNA differences between post-exercise groups. (a) miR-22-3p was not detectable in most of the START subjects (green squares above the blue line at Ct = 35). START had significantly less miR-22-3p than SC (yellow circles) and STOPP (red diamonds) as indicated by bars over top of the groups (HSD < 0.05, FDR < 0.10). In addition, SC had significantly more miR-22-3p than sc0 (grey circles). (b) miR-9-3p was detected in START, but was found in fewer than two thirds of subjects in the other groups. START had significantly more miRNA expression than STOPP (ΔΔCt = 1.6 ± 1.4, mean ± SD, HSD < 0.05, FDR < 0.10).
Figure 7
Figure 7
miRNAs that were significantly elevated in post-exercise compared to appropriate nonexercise control groups. Significant differences between groups were indicated by the bars at the top of the graphs for (a) miR-99b-5p, (b) miR-425-3p, (c) miR-30d-5p, (d) miR-204-5p, and (e) miR-370 (HSD ≤ 0.05, FDR ≤ 0.10, detected with Ct ≤ 35 in more than two thirds of one group per pair). The horizontal blue line indicated Ct = 35. Mean ± SD.
Figure 8
Figure 8
Decreased (a) miR-328 and (b) miR-608 levels in SC, CFS, START and STOPP groups after exercise.
Figure 9
Figure 9
miRNAs reduced by exercise. GWI phenotypes (START and STOPP) and CFS all had reductions in (a) miR-let-7i-5p, (b) miR-200a-5p and (c) miR-93-3p. Sedentary controls had no changes.
Figure 10
Figure 10
Decreased miRNAs after exercise in CFS group. CFS had significant reductions in -(a) 92a-3p, (b) miR-323b-5p, (c) miR-126-5p, (d) miR-19b-3p, (e) miR-505-3p, (f) miR-532-5p, and (g) miR-186-3p, compared to its nonexercise cfs0 comparison group (bars above the groups).

References

    1. Fukuda K, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 1994;121:953–9. doi: 10.7326/0003-4819-121-12-199412150-00009.
    1. Carruthers BM, et al. Myalgic Encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatments protocols. J. C. F. S. 2003;11:7–115.
    1. Carruthers BM, et al. Myalgic Encephalomyelitis: International Consensus Criteria. J. Intern. Med. 2011
    1. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. (Institute of Medicine, 2015).
    1. Centers for Disease Control and Prevention (CDC). Unexplained illness among Persian Gulf War veterans in an Air National Guard Unit: preliminary report–August 1990-March 1995. M.M.W.R. Morb. Mortal. Wkly. Rep. 44, 443–7 (1995).
    1. Fukuda K, et al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. J.A.M.A. 1998;280:981–8. doi: 10.1001/jama.280.11.981.
    1. Steele L. Prevalence and patterns of Gulf War illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service. Am. J. Epidemiol. 2000;152:992–1002. doi: 10.1093/aje/152.10.992.
    1. Gulf War Illness and the Health of Gulf War Veterans, 57 29–30 (Research Advisory Committee on Gulf War Veterans’ Illnesses, 2008).
    1. . Accessed January 2, 2017.
    1. Greenberg DB. Neurasthenia in the 1980s: chronic mononucleosis, chronic fatigue syndrome, and anxiety and depressive disorders. Psychosomatics. 1990;31:129–37. doi: 10.1016/S0033-3182(90)72185-8.
    1. Holmes GP, et al. A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? J.A.M.A. 1987;257:2297–302. doi: 10.1001/jama.1987.03390170053027.
    1. Roy MJ, Koslowe PA, Kroenke K, Magruder C. Signs, symptoms, and ill-defined conditions in Persian Gulf War veterans: findings from the Comprehensive Clinical Evaluation Program. Psychosom. Med. 1998;60:663–8. doi: 10.1097/00006842-199811000-00001.
    1. Naviaux RK, et al. Metabolic features of chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2016;113:E5472–80. doi: 10.1073/pnas.1607571113.
    1. Fluge Ø, et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. J.C.I. Insight. 2016;1:e89376.
    1. Barnden LR, et al. Evidence in chronic fatigue syndrome for severity-dependent upregulation of prefrontal myelination that is independent of anxiety and depression. N.M.R. Biomed. 2015;28:404–13.
    1. Barnden LR, et al. Autonomic correlations with MRI are abnormal in the brainstem vasomotor centre in Chronic Fatigue Syndrome. Neuroimage Clin. 2016;11:530–7. doi: 10.1016/j.nicl.2016.03.017.
    1. Iacob E, et al. Gene Expression Factor Analysis to Differentiate Pathways Linked to Fibromyalgia, Chronic Fatigue Syndrome, and Depression in a Diverse Patient Sample. Arthritis Care Res. (Hoboken). 2016;68:132–40. doi: 10.1002/acr.22639.
    1. Abdullah L, et al. Translational potential of long-term decreases in mitochondrial lipids in a mouse model of Gulf War Illness. Toxicology. 2016;372:22–33. doi: 10.1016/j.tox.2016.10.012.
    1. Steele L, et al. Complex factors in the etiology of Gulf War illness: wartime exposures and risk factors in veteran subgroups. Environ. Health Perspect. 2012;120:112–118. doi: 10.1289/ehp.1003399.
    1. Baraniuk JN, et al. A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid. BMC Neurol. 2005;5:22. doi: 10.1186/1471-2377-5-22.
    1. Steele L, et al. Butyrylcholinesterase genotype and enzyme activity in relation to Gulf War illness: preliminary evidence of gene-exposure interaction from a case-control study of 1991 Gulf War veterans. Environ. Health. 2015;14:4. doi: 10.1186/1476-069X-14-4.
    1. Rayhan RU, et al. Increased brain white matter axial diffusivity associated with fatigue, pain and hyperalgesia in Gulf War illness. PLoS One. 2013;8:e58493. doi: 10.1371/journal.pone.0058493.
    1. Chao LL, et al. Effects of low-level sarin and cyclosarin exposure and Gulf War Illness on brain structure and function: a study at 4T. Neurotoxicology. 2011;32:814–22. doi: 10.1016/j.neuro.2011.06.006.
    1. Koslik HJ, Hamilton G, Golomb BA. Mitochondrial dysfunction in Gulf War illness revealed by 31Phosphorus Magnetic Resonance Spectroscopy: a case-control study. PLoS One. 2014;9:e92887. doi: 10.1371/journal.pone.0092887.
    1. Rayhan RU, et al. Exercise challenge in Gulf War Illness reveals two subgroups with altered brain structure and function. PLoS One. 2013;8:e63903. doi: 10.1371/journal.pone.0063903.
    1. Liaw MY, et al. Central representation of phantom limb phenomenon in amputees studied with single photon emission computerized tomography. Am. J. Phys. Med. Rehabil. 1998;77:368–75. doi: 10.1097/00002060-199809000-00002.
    1. White RF, et al. Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: Effects of toxicant exposures during deployment. Cortex. 2016;74:449–75. doi: 10.1016/j.cortex.2015.08.022.
    1. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010;11:597–610. doi: 10.1038/nrg2843.
    1. Baraniuk JN, et al. A Chronic Fatigue Syndrome (CFS) severity score based on case designation criteria. Am. J. Transl. Res. 2013;5:53–68.
    1. Baraniuk JN, Clauw DJ, Gaumond E. Rhinitis symptoms in chronic fatigue syndrome. Ann. Allergy Asthma Immunol. 1998;81:359–65. doi: 10.1016/S1081-1206(10)63129-8.
    1. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care. 1992;30:473–83. doi: 10.1097/00005650-199206000-00002.
    1. Löwe B, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med. Care. 2008;46:266–274. doi: 10.1097/MLR.0b013e318160d093.
    1. Roberts RE, Vernon SW. The Center for Epidemiologic Studies Depression Scale: its use in a community sample. Am. J. Psychiatry. 1983;140:41–6. doi: 10.1176/ajp.140.1.41.
    1. Wolfe F, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160–72. doi: 10.1002/art.1780330203.
    1. Light AR, et al. Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome. J. Intern. Med. 2012;271:64–81. doi: 10.1111/j.1365-2796.2011.02405.x.
    1. Sørensen SS, Nygaard AB, Christensen T. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia - an exploratory study. Transl. Neurodegener. 2016;5:6. doi: 10.1186/s40035-016-0053-5.
    1. Shivapurkar N, et al. Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs. PLoS One. 2014;9:e84686. doi: 10.1371/journal.pone.0084686.
    1. LaConti. JJ, et al. Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. PLoS One. 2011;6:e20687. doi: 10.1371/journal.pone.0020687.
    1. Shivapurkar N, et al. Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer. Int. J. Colorectal Dis. 2014;28:887. doi: 10.1007/s00384-012-1560-1.
    1. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the Delta Delta C(t) method. Methods. 2001;25:402–8. doi: 10.1006/meth.2001.1262.
    1. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A practical and powerful approach to multiple testing. J. Royal Stat. Soc. B (Methodological). 1995;57:289–300.
    1. Cohen, J. Statistical power analysis for the behavioral sciences. (2nd ed.). (Lawrence Earlbaum Associates. 1988).
    1. Smylie AL, et al. A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome. BMC Immunol. 2013;14:29. doi: 10.1186/1471-2172-14-29.
    1. Hanin G. Competing targets of microRNA-608 affect anxiety and hypertension. Human Molecular Genetics. 2014;1:12.
    1. Keller BA, Pryor JL, Giloteaux L. Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment. J. Transl. Med. 2014;12:104. doi: 10.1186/1479-5876-12-104.
    1. Rayhan RU, et al. Prefrontal lactate predicts exercise-induced cognitive dysfunction in Gulf War Illness. Am. J. Transl. Res. 2013;5:212–23.
    1. Nielsen S, et al. The miRNA plasma signature in response to acute aerobic exercise and endurance training. PLoS One. 2014;9:e87308. doi: 10.1371/journal.pone.0087308.
    1. Wei YB, et al. Elevation of Il6 is associated with disturbed let-7 biogenesis in a genetic model of depression. Transl Psychiatry. 2016;6:e869. doi: 10.1038/tp.2016.136.
    1. Kim J, et al. miR-186 is decreased in aged brain and suppresses BACE1 expression. J. Neurochem. 2016;137:436–45. doi: 10.1111/jnc.13507.
    1. Wu Y, et al. Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer’s Disease. Tohoku J. Exp. Med. 2017;242:129–136. doi: 10.1620/tjem.242.129.
    1. Niu H, et al. miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11. Oncol. Rep. 2012;28:1771–7. doi: 10.3892/or.2012.1970.
    1. Cayrol R, et al. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 2008;9:137–45. doi: 10.1038/ni1551.
    1. Harris TA, et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 2008;105:516–1521. doi: 10.1073/pnas.0707493105.
    1. Jovičić. A, et al. Comprehensive expression analyses of neural cell-type- specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. J. Neurosci. 2013;33:5127–37. doi: 10.1523/JNEUROSCI.0600-12.2013.
    1. Deo M, Yu JY, Chung KH, Tippens M, Turner DL. Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev. Dyn. 2006;235:2538–2548. doi: 10.1002/dvdy.20847.
    1. Balusu S, et al. Identification of a novel mechanism of blood-brain communication during peripheral inflammation via choroid plexus-derived extracellular vesicles. E.M.B.O. Mol. Med. 2016;8:1162–83. doi: 10.15252/emmm.201606271.
    1. Falcão AM, et al. The path from the choroid plexus to the subventricular zone: go with the flow! Front. Cell. Neurosci. 2012;6:34. doi: 10.3389/fncel.2012.00034.
    1. Keep RF, Jones HC. A morphometric study on the development of the lateral ventricle choroid plexus, choroid plexus capillaries and ventricular ependyma in the rat. Brain Res. Dev. Brain. Res. 1990;56:47–53. doi: 10.1016/0165-3806(90)90163-S.
    1. Nilsson C, Lindvall-Axelsson M, Owman C. Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system. Brain Res. Brain Res. Rev. 1992;17:109–38. doi: 10.1016/0165-0173(92)90011-A.
    1. Marques F, et al. The choroid plexus response to a repeated peripheral inflammatory stimulus. BMC Neurosci. 2009;10:135. doi: 10.1186/1471-2202-10-135.
    1. Marques F, et al. Kinetic profile of the transcriptome changes induced in the choroid plexus by peripheral inflammation. J. Cereb. Blood Flow Metab. 2009;29:921–32. doi: 10.1038/jcbfm.2009.15.
    1. Rutnam ZJ, Yang BB. The non-coding 3′ UTR of CD44 induces metastasis by regulating extracellular matrix functions. J. Cell Sci. 2012;125:2075–85. doi: 10.1242/jcs.100818.
    1. Bátiz LF, et al. Exosomes as novel regulators of adult neurogenic niches. Front. Cell Neurosci. 2016;9:501. doi: 10.3389/fncel.2015.00501.
    1. Akers JC, et al. miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients. J Neurooncol. 2015;123:205–16. doi: 10.1007/s11060-015-1784-3.
    1. Doetsch F, et al. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999;97:703–716. doi: 10.1016/S0092-8674(00)80783-7.
    1. Fuentealba LC, Obernier K, Alvarez-Buylla A. Adult neural stem cells bridge their niche. Cell. Stem Cell. 2012;10:698–708. doi: 10.1016/j.stem.2012.05.012.
    1. Baruch K, Schwartz M. CNS-specific T cells shape brain function via the choroid plexus. Brain Behav. Immun. 2013;34:11–6. doi: 10.1016/j.bbi.2013.04.002.
    1. Bergen AA, et al. Gene expression and functional annotation of human choroid plexus epithelium failure in Alzheimer’s disease. BMC Genomics. 2015;16:956. doi: 10.1186/s12864-015-2159-z.
    1. Alexandrov PN, et al. microRNA (miRNA) speciation in Alzheimer’s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF) Int. J. Biochem. Mol. Biol. 2012;3:365–73.
    1. Dangla-Valls, A. et al. CSF microRNA profiling in Alzheimer’s Disease: a screening and validation study. Mol. Neurobiol. 2016 Oct 13. [Epub ahead of print].
    1. Kiko T, et al. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer’s disease. J. Alzheimers Dis. 2014;39:253–9.
    1. Müller M, et al. MicroRNA-29a is a candidate biomarker for Alzheimer’s disease in cell-free cerebrospinal fluid. Mol. Neurobiol. 2016;53:2894–9. doi: 10.1007/s12035-015-9156-8.
    1. Denk J, et al. MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer’s disease. PLoS One. 2015;10:e0126423. doi: 10.1371/journal.pone.0126423.
    1. van Harten AC, Mulders J, Scheltens P, van der Flier WM, Oudejans CB. Differential expression of microRNA in cerebrospinal fluid as a potential novel biomarker for Alzheimer’s disease. J. Alzheimers Dis. 2015;47:243–52. doi: 10.3233/JAD-140075.
    1. Blore JD, Sim MR, Forbes AB, Creamer MC, Kelsall HL. Depression in Gulf War veterans: a systematic review and meta-analysis. Psychol. Med. 2015;45:1565–1580. doi: 10.1017/S0033291714001913.
    1. Stimpson NJ, Thomas HV, Weightman AL, Dunstan F, Lewis G. Psychiatric disorder in veterans of the Persian Gulf War of 1991. Systematic review. Br. J. Psychiatry. 2003;182:391–403. doi: 10.1192/bjp.182.5.391.
    1. Valero S, et al. The role of neuroticism, perfectionism and depression in chronic fatigue syndrome. A structural equation modeling approach. Compr. Psychiatry. 2013;54:1061–7. doi: 10.1016/j.comppsych.2013.04.015.
    1. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. (American Psychiatric Association, Washington, DC, 1994).
    1. McKenzie DP, et al. Developing a brief depression screen and identifying associations with comorbid physical and psychological illness in Australian Gulf War veterans. J. Psychosom. Res. 2015;79:566–73. doi: 10.1016/j.jpsychores.2015.08.003.
    1. Shafer AB. Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J. Clin. Psychol. 2006;62:123–46. doi: 10.1002/jclp.20213.
    1. Clarke DM, McKenzie DP. A caution on the use of cut-points applied to screening instruments or diagnostic criteria. J. Psychiatr. Res. 1994;28:185–8. doi: 10.1016/0022-3956(94)90029-9.
    1. Nanthakumar S, Bucks RS, Skinner TC. Are we overestimating the prevalence of depression in chronic illness using questionnaires? Meta-analytic evidence in obstructive sleep apnoea. Health Psychol. 2016;35:423–32. doi: 10.1037/hea0000280.
    1. Pincus T, Hassett AL, Callahan LF. Criterion contamination of depression scales in patients with rheumatoid arthritis: the need for interpretation of patient questionnaires (as all clinical measures) in the context of all information about the patient. Rheum. Dis. Clin. North. Am. 2009;35:861–4. doi: 10.1016/j.rdc.2009.10.015.
    1. Dwivedi Y. Pathogenetic and therapeutic applications of microRNAs in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2016;64:341–8. doi: 10.1016/j.pnpbp.2015.02.003.
    1. Song MF, et al. CSF miR-16 is decreased in major depression patients and its neutralization in rats induces depression-like behaviors via a serotonin transmitter system. J. Affect. Disord. 2015;178:25–31. doi: 10.1016/j.jad.2015.02.022.
    1. Wan Y, et al. Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder. PLoS One. 2015;10:e0121975. doi: 10.1371/journal.pone.0121975.
    1. Bjersing JL, et al. Profile of cerebrospinal microRNAs in fibromyalgia. PLoS One. 2013;8:e78762. doi: 10.1371/journal.pone.0078762.
    1. McAlexander MA, Phillips MJ, Witwer KW. Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from cerebrospinal fluid. Front. Genet. 2013;4:83. doi: 10.3389/fgene.2013.00083.
    1. Andersen. CL, Jensen JL, Ørntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64:5245–50. doi: 10.1158/0008-5472.CAN-04-0496.
    1. Burgos K, et al. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer’s and Parkinson’s diseases correlate with disease status and features of pathology. PLoS One. 2014;9:e94839. doi: 10.1371/journal.pone.0094839.
    1. Nassirpour R, et al. Identification of tubular injury microRNA biomarkers in urine: comparison of next-generation sequencing and qPCR-based profiling platforms. BMC Genomics. 2014;15:485. doi: 10.1186/1471-2164-15-485.
    1. Kuner R, Brase JC, Sültmann H, Wuttig D. microRNA biomarkers in body fluids of prostate cancer patients. Methods. 2013;59:132–7. doi: 10.1016/j.ymeth.2012.05.004.
    1. Baraniuk, J. N. & Shivapurkar, N. Cerebrospinal fluid MicroRNA (miRNA) in CFS and Gulf War Illness (GWI). International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFSME). Fort Lauderdale FLA, Oct. 2016.
    1. Brenu EW, et al. High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis. PLoS One. 2014;9:e102783. doi: 10.1371/journal.pone.0102783.
    1. Lopez JP, et al. MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes. Nat. Commun. 2017;8:15497. doi: 10.1038/ncomms15497.

Source: PubMed

3
Suscribir